Remimazolam Bolus Prevents Emergence Agitation After Rhinologic Surgery: A Randomized, Triple-Blind, Controlled Trial
Medical Sciences · 2026
DOI: 10.3390/medsci14010129 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Medical Sciences, 2026. Verfasst von Grgur Prižmić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Division of Anaesthesiology, University Hospital of Split, 21000 Split, Croatia. Hauptthemen laut MEDLINE: Benzodiazepines, Emergence Delirium, Nasal Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Emergence agitation (EA) is common after rhinologic surgery and may cause self-injury, bleeding, and prolonged post-anesthesia care unit (PACU) stay. Remimazolam is an ultra-short-acting benzodiazepine that may reduce EA without delaying recovery. The objective of this study was to evaluate the effect of a single dose of remimazolam administered at the end of surgery on the incidence of EA in adult patients undergoing nasal surgery.
Methods
In this prospective, randomized, triple-blind, placebo-controlled trial, 62 adults undergoing elective rhinologic surgery under sevoflurane anesthesia received either remimazolam 0.1 mg/kg or saline immediately after sevoflurane discontinuation and before extubation. EA was assessed using the Richmond Agitation–Sedation Scale (RASS) at extubation and every 5 min for 30 min in the PACU. The primary outcome was presence of EA (RASS ≥ 2) at extubation. Secondary outcomes included Aldrete recovery scores, VAS, PONV incidence and safety outcomes. The study was registered at ClinicalTrials.gov (NCT06398275; 3 May 2024).
Results
EA occurred in 12/32 patients (37.5%) in the control group and 0/30 (0%) in the remimazolam group (p < 0.001). Extubation time and operative durations were similar between groups. More patients in the remimazolam group achieved an Aldrete score ≥ 9 at extubation (76.7% vs. 50.0%, p = 0.030). Severe agitation (RASS ≥ 3) requiring rescue sedation occurred in 6/32 control-group patients and in 0/30 patients in the remimazolam group (p = 0.025). Pain scores were low (no VAS > 2). PONV occurred in one patient per group. Clinically relevant postoperative nasal bleeding requiring intervention occurred in 2/32 control-group patients and in 0/30 remimazolam-group patients. No laryngospasm or respiratory complications within 24 h were observed.
Conclusions
A single remimazolam bolus given at the end of surgery prevented clinically relevant EA after rhinologic surgery without delaying early recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, Division of Anaesthesiology, University Hospital of Split, 21000 Split, Croatia.
- School of Medicine, University of Split, 21000 Split, Croatia.
ORCID-Profile: Grgur Prižmić, Marinela Jozeljić Pešić, Ana Maria Mitar, Ana Bego, Sanja Pavičić Perković, Sanda Stojanović Stipić
Zitieren
APA
Prižmić, G., Periš, F., Jozeljić Pešić, M., Mitar, A. M., Bego, A., Perković, S. P., & Stojanović Stipić, S. (2026). Remimazolam Bolus Prevents Emergence Agitation After Rhinologic Surgery: A Randomized, Triple-Blind, Controlled Trial. Medical Sciences. https://doi.org/10.3390/medsci14010129
Vancouver
Prižmić G, Periš F, Jozeljić Pešić M, Mitar AM, Bego A, Perković SP, et al. Remimazolam Bolus Prevents Emergence Agitation After Rhinologic Surgery: A Randomized, Triple-Blind, Controlled Trial. Medical Sciences. 2026. doi:10.3390/medsci14010129
BibTeX
@article{Primi2026,
author = {Prižmić, Grgur and Periš, Filip and Jozeljić Pešić, Marinela and Mitar, Ana Maria and Bego, Ana and Perković, Sanja Pavičić and Stojanović Stipić, Sanda},
title = {Remimazolam Bolus Prevents Emergence Agitation After Rhinologic Surgery: A Randomized, Triple-Blind, Controlled Trial},
journal = {Medical Sciences},
year = {2026},
doi = {10.3390/medsci14010129}
}
EUVIMED